表紙
市場調查報告書
商品編碼
980011

抗發炎藥市場 - 市場規模,佔有率,預測,機會分析:2020年∼2027年

Anti-inflammatory Drugs Market, by Drug Type, by Application, by Route of Administration, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

出版日期: | 出版商: Coherent Market Insights | 英文 200 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

預計全球抗炎藥市場將隨著關節炎等急/慢性疾病的發病率上升而推動市場增長。

本報告提供全球抗發炎藥市場相關調查分析,提供市場概要,市場規模與預測,各市場區隔的市場分析,各地區的市場分析,競爭情形等相關的系統性資訊。

目錄

第1章 調查目的與前提條件

第2章 市場範圍

第3章 市場動態·規定·趨勢分析

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
  • 影響分析
  • 開發平台分析
  • 給付方案
  • 流行病學
  • PEST分析
  • 法規方案
  • 新產品的銷售
  • 合作與契約
  • 市場趨勢

第4章 全球抗發炎藥市場:COVID-19疫情的影響

  • COVID-19市場方案
  • COVID-19對該市場的影響

第5章 全球抗發炎藥市場:各藥物類型

  • 簡介
  • 非類固醇消炎劑 (NSAID)
  • 免疫選擇的抗發炎衍生物 (ImSAID)
  • 抗發炎生技藥品
  • 皮質類固醇

第6章 全球抗發炎藥市場:各適應症

  • 簡介
  • 關節炎
  • 慢性阻塞性肺病 (COPD)
  • 多發性硬化症
  • 發炎性腸道疾病 (IBD)
  • 痛風
  • 其他

第7章 全球抗發炎藥市場:各給藥途徑

  • 簡介
  • 口服
  • 局部
  • 注射
  • 吸入

第8章 全球抗發炎藥市場:各流通管道

  • 簡介
  • 醫院藥局
  • 零售藥局
  • 線上藥局

第9章 全球抗發炎藥市場:各地區

  • 簡介
  • 北美
  • 南美
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第10章 競爭情形

  • 熱圖分析
  • 市場佔有率分析
    • Pfizer, Inc.
    • GlaxoSmithKline plc
    • Johnson & Johnson Services Inc.
    • Merck & Company, Inc.
    • Novartis AG
    • Amgen, Inc.
    • AstraZeneca plc
    • Eli Lily and Company
    • AbbVie Inc.
    • F. Hoffmann-La Roche AG
    • Bristol Myers Squibb Company
    • Biogen Inc.
    • Sun Pharmaceutical Industries Ltd
    • Mylan, Inc.
    • Aurobindo Pharma Limited
    • Dr. Reddy's Laboratories
    • 分析師的見解

第11章 章節

目錄

Title:
Anti-inflammatory Drugs Market, by Drug Type (Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Immune Selective Anti-inflammatory Derivatives (ImSAIDs), Anti-inflammatory Biologics, and Corticosteroids), by Application (Arthritis, Chronic Obstructive Pulmonary Disease (COPD), Multiple Sclerosis, Inflammatory Bowel Disease (IBD), Gout, and Others), by Route of Administration (Oral, Topical, Injection, and Inhalation), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

Anti-inflammatory drugs are used in the treatment of acute and chronic diseases with inflammatory etiology. Therapeutic delivery of anti-inflammatory drugs to the target site of action and simultaneously avoiding undesired side effects. Anti-inflammatory drug supports to improve the quality of life and management of several rheumatic conditions such as arthritis. Anti-inflammatory drugs, especially the non-steroidal forms has significant role in medical practice, which has strong potential to boost the market growth in the near future.

Market Dynamics

Rising incidence of acute and chronic diseases such as arthritis is expected to drive anti-inflammatory drugs market growth. For instance, according to an article published by the Morbidity and Mortality Weekly Report, an epidemiological digest Centers for Disease Control and Prevention (CDC) in 2017, reports that arthritis affects over 1 in 4 adults and in rural areas in the U.S., 1 in 3 adults has arthritis.

However, side effects of anti-inflammatory drugs are expected to hinder the market growth. For instance, according to an article published by the healthdirect, Australia in January 2020, reports that the anti-inflammatory medicines may also trigger asthma in some people. The same source also states that children under 16 years must not be prescribed aspirin due to the rare occurrence of Reye's syndrome, which is potentially fatal.

Key features of the study:

  • This report provides in-depth analysis of the global anti-inflammatory drugs market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2020-2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global anti-inflammatory drugs market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Pfizer, Inc., GlaxoSmithKline plc, Johnson & Johnson Services Inc., Merck & Company, Inc., Novartis AG, Amgen, Inc., AstraZeneca plc, Eli Lily and Company, AbbVie Inc., F. Hoffmann-La Roche AG, Bristol Myers Squibb Company, Biogen Inc., Sun Pharmaceutical Industries Ltd, Mylan, Inc., Aurobindo Pharma Limited, and Dr. Reddy's Laboratories among others
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future drug launches, drug class up-gradation, market expansion, and marketing tactics
  • The global anti-inflammatory drugs market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global anti-inflammatory drugs market.

Detailed Segmentation:

  • Global Anti-inflammatory Drugs Market, By Drug Type:
    • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
    • Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
    • Anti-inflammatory Biologics
    • Corticosteroids
  • Global Anti-inflammatory Drugs Market, By Application:
    • Arthritis
    • Chronic Obstructive Pulmonary Disease (COPD)
    • Multiple Sclerosis
    • Inflammatory Bowel Disease (IBD)
    • Gout
    • Others
  • Global Anti-inflammatory Drugs Market, By Route of Administration:
    • Oral
    • Topical
    • Injection
    • Inhalation
  • Global Anti-inflammatory Drugs Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Anti-inflammatory Drugs Market, By Region:
    • North America
      • By Drug Type:
      • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
      • Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
      • Anti-inflammatory Biologics
      • Corticosteroids
      • By Application:
      • Arthritis
      • Chronic Obstructive Pulmonary Disease (COPD)
      • Multiple Sclerosis
      • Inflammatory Bowel Disease (IBD)
      • Gout
      • Others
      • By Route of Administration:
      • Oral
      • Topical
      • Injection
      • Inhalation
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • U.S.
      • Canada
    • Latin America
      • By Drug Type:
      • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
      • Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
      • Anti-inflammatory Biologics
      • Corticosteroids
      • By Application:
      • Arthritis
      • Chronic Obstructive Pulmonary Disease (COPD)
      • Multiple Sclerosis
      • Inflammatory Bowel Disease (IBD)
      • Gout
      • Others
      • By Route of Administration:
      • Oral
      • Topical
      • Injection
      • Inhalation
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Drug Type:
      • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
      • Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
      • Anti-inflammatory Biologics
      • Corticosteroids
      • By Application:
      • Arthritis
      • Chronic Obstructive Pulmonary Disease (COPD)
      • Multiple Sclerosis
      • Inflammatory Bowel Disease (IBD)
      • Gout
      • Others
      • By Route of Administration:
      • Oral
      • Topical
      • Injection
      • Inhalation
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Drug Type:
      • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
      • Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
      • Anti-inflammatory Biologics
      • Corticosteroids
      • By Application:
      • Arthritis
      • Chronic Obstructive Pulmonary Disease (COPD)
      • Multiple Sclerosis
      • Inflammatory Bowel Disease (IBD)
      • Gout
      • Others
      • By Route of Administration:
      • Oral
      • Topical
      • Injection
      • Inhalation
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Drug Type:
      • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
      • Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
      • Anti-inflammatory Biologics
      • Corticosteroids
      • By Application:
      • Arthritis
      • Chronic Obstructive Pulmonary Disease (COPD)
      • Multiple Sclerosis
      • Inflammatory Bowel Disease (IBD)
      • Gout
      • Others
      • By Route of Administration:
      • Oral
      • Topical
      • Injection
      • Inhalation
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Drug Type:
      • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
      • Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
      • Anti-inflammatory Biologics
      • Corticosteroids
      • By Application:
      • Arthritis
      • Chronic Obstructive Pulmonary Disease (COPD)
      • Multiple Sclerosis
      • Inflammatory Bowel Disease (IBD)
      • Gout
      • Others
      • By Route of Administration:
      • Oral
      • Topical
      • Injection
      • Inhalation
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country/Region:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Pfizer, Inc.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • GlaxoSmithKline plc
    • Johnson & Johnson Services Inc.
    • Merck & Company, Inc.
    • Novartis AG
    • Amgen, Inc.
    • AstraZeneca plc
    • Eli Lily and Company
    • AbbVie Inc.
    • F. Hoffmann-La Roche AG
    • Bristol Myers Squibb Company
    • Biogen Inc.
    • Sun Pharmaceutical Industries Ltd
    • Mylan, Inc.
    • Aurobindo Pharma Limited
    • Dr. Reddy's Laboratories

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Drug Type
    • Market Snippet, By Application
    • Market Snippet, By Route of Administration
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Pipeline Analysis
  • Reimbursement Scenario
  • Epidemiology
  • Pest Analysis
  • Regulatory Scenario
  • New Product Launches
  • Collaborations and Agreements
  • Market Trends

4. Global Anti-inflammatory Drugs Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Market Scenario
  • Impact of COVID-19 Market on the Anti-inflammatory Drugs Products

5. Global Anti-inflammatory Drugs Market, By Drug Type, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Anti-inflammatory Biologics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Corticosteroids
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

6. Global Anti-inflammatory Drugs Market, By Application, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Arthritis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Chronic Obstructive Pulmonary Disease (COPD)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Multiple Sclerosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Inflammatory Bowel Disease (IBD)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Gout
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

7. Global Anti-inflammatory Drugs Market, By Route of Administration, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Topical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Injection
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Inhalation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

8. Global Anti-inflammatory Drugs Market, By Distribution Channel, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

9. Global Anti-inflammatory Drugs Market, By Region, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2027
  • North America
    • Market Size and Forecast, By Drug Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Route of Administration, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Drug Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Route of Administration, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Drug Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Route of Administration, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Drug Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Route of Administration, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Drug Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Route of Administration, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Drug Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Route of Administration, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country/Region, 2016 - 2027, (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

10. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
    • Pfizer, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • GlaxoSmithKline plc
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Johnson & Johnson Services Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Merck & Company, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Novartis AG
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Amgen, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • AstraZeneca plc
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Eli Lily and Company
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • AbbVie Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • F. Hoffmann-La Roche AG
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Bristol Myers Squibb Company
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Biogen Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Sun Pharmaceutical Industries Ltd
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Mylan, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Aurobindo Pharma Limited
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Dr. Reddy's Laboratories
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Analyst Views

11. Section

  • References
  • Research Methodology
  • About us and Sales Contact